More on SXTP

- Summary
- Chart
- Profile
- Historical

Data

- Ratings (5.0 Score)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

60 Degrees (NQ:SXTP)
Delayed: 1.48 -0.01 (0.67%)
Prev. Close $1.49  
Open$1.52 
52 Wk High$ 
52 Wk Low$ 
Day High$1.56 
Day Low$1.42 
P/E N/A  
EPS$ 
Volume58,580 

Friends, Peers and Foes (?): SXTPW, BIVI, GDRX, BFRG, LTRN (more...)

Jul 20, 2026 04:06 PM Form 8-K 60 DEGREES PHARMACEUTICA For: Jul 20
Jul 9, 2026 04:06 PM Form 8-K 60 DEGREES PHARMACEUTICA For: Jul 07
Jul 8, 2026 08:01 AM 60 Degrees Pharma signs option deal with Florida State for tick disease compound
Jul 8, 2026 08:01 AM 60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases
Jul 2, 2026 04:06 PM Form DEF 14A 60 DEGREES PHARMACEUTICA For: Aug 05
Jul 1, 2026 08:02 AM 60 Degrees Pharma gets safety board clearance for babesiosis trial
Jul 1, 2026 08:02 AM 60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
Jun 15, 2026 04:51 PM Form 4 60 DEGREES PHARMACEUTICA For: Jun 12 Filed by: DOW GEOFFREY S
Jun 11, 2026 08:03 AM 60 Degrees Pharmaceuticals licenses Australian chestnut patent
Jun 11, 2026 08:03 AM 60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
View All Articles

Entities mentioned with SXTP

View All Entities